Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA Drug Recalls

18,003 recalls, newest first

Class II · Moderate risk

Extra Strength Headache

CGMP Deviations: manufacturer recalled after an FDA inspection noted that these products were not manufactured under Current Good Manufacturing Practices.

Terminated cGMP deviation Medique Products D-0391-2022
Class II · Moderate risk

Medique Pain-Off

CGMP Deviations: manufacturer recalled after an FDA inspection noted that these products were not manufactured under Current Good Manufacturing Practices.

Terminated cGMP deviation Medique Products D-0390-2022
Class II · Moderate risk

Physicians CARE Extra Strength PAIN RELIEVER

CGMP Deviations: manufacturer recalled after an FDA inspection noted that these products were not manufactured under Current Good Manufacturing Practices.

Terminated cGMP deviation Medique Products D-0389-2022
Class I · High risk

kleantouch HAND SANITIZER

Marketed Without an Approved NDA/ANDA: Product labeled to contain methanol making it an unapproved new drug and contains methanol

Terminated Unapproved drug Valisa MFG LLC D-0363-2022
Class III · Low risk

CTx36 Kit

Subpotent Drug: Product contains less Sodium Fluoride than listed on product label.

Terminated Wrong potency / content Dental Alliance Holdings LLC D-0457-2022
Class III · Low risk

CTx26 Kit

Subpotent Drug: Product contains less Sodium Fluoride than listed on product label.

Terminated Wrong potency / content Dental Alliance Holdings LLC D-0456-2022
Class III · Low risk

CTx21 Kit

Subpotent Drug: Product contains less Sodium Fluoride than listed on product label.

Terminated Wrong potency / content Dental Alliance Holdings LLC D-0455-2022
Class III · Low risk

CTx7 Kit

Subpotent Drug: Product contains less Sodium Fluoride than listed on product label.

Terminated Wrong potency / content Dental Alliance Holdings LLC D-0454-2022
Class I · High risk

Veklury (remdesivir)

Presence of Particulate Matter: investigation into a customer complaint confirmed the presence of glass particulates.

Terminated Particulate / foreign matter Gilead Sciences, Inc. NDC 61958-2901-2 D-0299-2022
Class II · Moderate risk

B-Complex

Lack of Processing Controls

Terminated cGMP deviation Valgene Incorporated dba Cape Drugs D-0284-2022

Recalls by year